Skip to main content
. Author manuscript; available in PMC: 2018 Jun 15.
Published in final edited form as: Biopolymers. 2017 Sep;108(5):10.1002/bip.23026. doi: 10.1002/bip.23026

Table 4.

Potencies and efficacies of the Dyn B amide alanine analogs at KOR in the GTPγS assay

Peptide EC50 (nM ± SEM)a,b
N-Terminal alanine substituted analogs
1 [Ala1] 2650 ± 890
2 [Ala4] 1180 ± 330
C-Terminal alanine substituted analogs
3 [Ala5] 109 ± 34
4 [Ala6] 116 ± 21
5 [Ala7] 802 ± 290
6 [Ala8] 20.2 ± 10.8
7 [Ala9] 14.8 ± 2.6
8 [Ala10] 6.36 ± 1.70
9 [Ala11] 8.79 ± 2.20
Dyn B NH2 9.14 ± 1.96
a

Values are for n ≥ 2.

b

All analogs exhibited ≥90% efficacy as compared to Dyn A(1-13)NH2 (efficacy = 100%) except for Ala10 (86 ± 3% efficacy).